ProPhase Labs’ Nebula Genomics Subsidiary Introduces Lowest Ever NGS Pricing of $249 for its Whole Genome Sequencing DNA Test Company Provides Update on Significant Progress at Nebula Genomics Subsidiary Garden City, NY, March 07, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented...

American Song Contest Star Cruz Rock to Go New Ways in Music Monetization LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) -- Nebula Ltd. announces Cruz Rock to its expanding roster of talented musicians. The Latin Caribbean singer-songwriter will offer fractional ownership of...

ProPhase Labs Provides Business Update Garden City, NY, Oct. 13, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announces that it expects its Q3 2021 COVID-19 testing...

NebulaECN Launches Instant Deep Liquidity and Radical Transparency for Crypto Market TALLINN, Estonia, March 15, 2021 (GLOBE NEWSWIRE) -- Despite top crypto assets demonstrating impressive daily trading volumes, cryptocurrencies remain a thinly traded market, due to its...